Erschienen in:
01.09.2013 | Original Article
No effect of menstrual cycle phase on glucose and glucoregulatory endocrine responses to prolonged exercise
verfasst von:
Robert R. Kraemer, Michelle Francois, Nancy Dardis Webb, Jennifer R. Worley, Sharon N. Rogers, Reid L. Norman, Urvi Shah, V. Daniel Castracane
Erschienen in:
European Journal of Applied Physiology
|
Ausgabe 9/2013
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Prolonged exercise requires increased utilization of blood glucose and adjustment of glucoregulatory hormones. Estrogen can reduce hepatic gluconeogenesis which could affect insulin concentrations. Amylin is co-secreted with insulin and controls influx of glucose into the blood.
Purpose
To determine the effect of menstrual cycle stage on glucose, leptin, and pancreatic hormone responses to prolonged (90 min) exercise.
Methods
Five healthy, eumenorrheic women (24.6 ± 5.1 years; 67.4 ± 1 kg) were monitored for 3 months to determine menstrual cycle length. Subjects completed a preliminary session to determine exercise workloads and, in a fasted condition, completed two randomized 90-min treadmill exercise trials at 60 % VO2max during the early follicular (EFX) and mid-luteal phase (MLX) of their menstrual cycle. Blood samples were analyzed for glucose, insulin, C-peptide, amylin, glucagon, leptin, and cortisol concentrations at rest (−30 and 0 min), during exercise (18, 36, 54, 72, and 90 min) and after 20 min of recovery.
Results
No changes in amylin, leptin, or cortisol occurred for EFX and MLX trials. A significant (p < 0.05) time effect occurred for glucose, insulin, and glucagon with reduced insulin across the exercise trial and increases in glucose and glucagon later in the trial, but there were no differences between the EFX and MLX trials.
Conclusions
Menstrual cycle stage does not affect glucose, insulin, C-peptide, amylin, glucagon, cortisol, and leptin responses to prolonged exercise; however, the exercise reduces insulin and increases glucose and glucagon concentrations. This is the first study to determine acute effects of exercise on amylin and other glucoregulatory hormone responses in women.